Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

909 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
Fleischhauer K, Shaw BE, Gooley T, Malkki M, Bardy P, Bignon JD, Dubois V, Horowitz MM, Madrigal JA, Morishima Y, Oudshoorn M, Ringden O, Spellman S, Velardi A, Zino E, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Fleischhauer K, et al. Among authors: morishima y. Lancet Oncol. 2012 Apr;13(4):366-74. doi: 10.1016/S1470-2045(12)70004-9. Epub 2012 Feb 15. Lancet Oncol. 2012. PMID: 22340965 Free PMC article.
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group. Hsu KC, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36. doi: 10.1016/j.bbmt.2006.04.008. Biol Blood Marrow Transplant. 2006. PMID: 16864053 Free article. Clinical Trial.
Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y, Yabe T, Matsuo K, Kashiwase K, Inoko H, Saji H, Yamamoto K, Maruya E, Akatsuka Y, Onizuka M, Sakamaki H, Sao H, Ogawa S, Kato S, Juji T, Sasazuki T, Kodera Y; Japan Marrow Donor Program. Morishima Y, et al. Biol Blood Marrow Transplant. 2007 Mar;13(3):315-28. doi: 10.1016/j.bbmt.2006.10.027. Biol Blood Marrow Transplant. 2007. PMID: 17317585 Free article.
Significance of ethnicity in the risk of acute graft-versus-host disease and leukemia relapse after unrelated donor hematopoietic stem cell transplantation.
Morishima Y, Kawase T, Malkki M, Morishima S, Spellman S, Kashiwase K, Kato S, Cesbron A, Tiercy JM, Senitzer D, Velardi A, Petersdorf EW; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Morishima Y, et al. Among authors: morishima s. Biol Blood Marrow Transplant. 2013 Aug;19(8):1197-203. doi: 10.1016/j.bbmt.2013.05.020. Epub 2013 Jun 6. Biol Blood Marrow Transplant. 2013. PMID: 23747601 Free PMC article.
Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
Petersdorf EW, Carrington M, O'hUigin C, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Maiers MJ, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Stevenson P; International Histocompatibility Working Group in Hematopoietic Cell Transplantation. Petersdorf EW, et al. Among authors: morishima y. Lancet Haematol. 2020 Jan;7(1):e50-e60. doi: 10.1016/S2352-3026(19)30208-X. Epub 2019 Oct 25. Lancet Haematol. 2020. PMID: 31669248 Free PMC article.
Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status.
Carapito R, Aouadi I, Pichot A, Spinnhirny P, Morlon A, Kotova I, Macquin C, Rolli V, Cesbron A, Gagne K, Oudshoorn M, van der Holt B, Labalette M, Spierings E, Picard C, Loiseau P, Tamouza R, Toubert A, Parissiadis A, Dubois V, Paillard C, Maumy-Bertrand M, Bertrand F, von dem Borne PA, Kuball JHE, Michallet M, Lioure B, Peffault de Latour R, Blaise D, Cornelissen JJ, Yakoub-Agha I, Claas F, Moreau P, Charron D, Mohty M, Morishima Y, Socié G, Bahram S. Carapito R, et al. Among authors: morishima y. Bone Marrow Transplant. 2020 Jul;55(7):1367-1378. doi: 10.1038/s41409-020-0886-5. Epub 2020 Apr 14. Bone Marrow Transplant. 2020. PMID: 32286503 Free article.
Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
Petersdorf EW, Bengtsson M, De Santis D, Dubois V, Fleischhauer K, Gooley T, Horowitz M, Madrigal JA, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Stevenson P, Carrington M; the; International Histocompatibility Working Group in Hematopoietic-Cell Transplantation. Petersdorf EW, et al. Among authors: morishima y. J Clin Oncol. 2020 Aug 20;38(24):2712-2718. doi: 10.1200/JCO.20.00265. Epub 2020 Jun 1. J Clin Oncol. 2020. PMID: 32479188 Free PMC article.
HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation.
Petersdorf EW, Stevenson P, Bengtsson M, De Santis D, Dubois V, Gooley T, Horowitz M, Hsu K, Madrigal JA, Malkki M, McKallor C, Morishima Y, Oudshoorn M, Spellman SR, Villard J, Carrington M. Petersdorf EW, et al. Among authors: morishima y. Blood. 2020 Jul 16;136(3):362-369. doi: 10.1182/blood.2020005743. Blood. 2020. PMID: 32483623 Free PMC article.
Race and Survival in Unrelated Hematopoietic Cell Transplantation.
Morishima Y, Morishima S, Stevenson P, Kodera Y, Horowitz M, McKallor C, Malkki M, Spellman SR, Gooley T, Petersdorf EW; on-behalf-of-the-International Histocompatibility-Working-Group-in-Hematopoietic-Cell-Transplantation. Morishima Y, et al. Among authors: morishima s. Transplant Cell Ther. 2022 Jul;28(7):357.e1-357.e6. doi: 10.1016/j.jtct.2022.03.026. Epub 2022 Apr 8. Transplant Cell Ther. 2022. PMID: 35405366 Free PMC article.
909 results